Stem cell-based therapies for heart failure management: a narrative review of current evidence and future

Gbolahan Olatunji1, Emmanuel Kokori1, Ismaila Yusuf2

  • 1Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria.

Heart Failure Reviews
|September 21, 2023
PubMed

Insights

Stem cell therapies offer a promising new avenue for treating heart failure (HF), potentially improving cardiac function and quality of life. Rigorous safety assessments and personalized approaches are crucial for future advancements in this field.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Heart failure (HF) affects millions globally, necessitating novel treatments beyond symptom management.
  • Current therapies for HF primarily focus on alleviating symptoms rather than addressing root causes.
  • The rising prevalence of HF demands innovative therapeutic strategies to restore cardiac function.

Purpose of the Study:

  • To review the current status of stem cell-based therapies for heart failure management.
  • To explore the mechanisms, clinical evidence, ethical considerations, and regulatory aspects of these therapies.
  • To identify future directions for enhancing the efficacy and safety of stem cell treatments for HF.

Main Methods:

  • Comprehensive literature review of stem cell-based therapies for heart failure.
  • Analysis of clinical trial data, including both positive and negative outcomes.
  • Examination of ethical considerations and regulatory hurdles in stem cell therapy development.

Main Results:

  • Stem cell therapies demonstrate potential for improving cardiac function and patient quality of life in HF.
  • Evidence suggests possible long-term benefits, but adverse events necessitate thorough safety evaluations.
  • Optimizing stem cell types, delivery, and dosage are key to enhancing therapeutic outcomes.

Conclusions:

  • Stem cell therapies represent a significant advancement in heart failure treatment, moving beyond conventional approaches.
  • Further research is needed to refine safety protocols, personalize treatments, and address ethical/regulatory challenges.
  • Expanding access and reducing costs are vital for the widespread adoption of these innovative therapies.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14